Framework Journal · one stock, one dated entry

Recorded 2025-12-31 · Permanent

IM Cannabis Corp IMCC

Outside both standards

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

In plain words · IM Cannabis Corp.

The label
Markdown

read at $0.14

IM Cannabis Corp holds its Markdown at $0.14.

PHINPOOPSC
  • PHPhase · the trend structure carries the Markdown label
  • INInsiders · no filings inside 60 days, left as found
  • POPositioning · no disclosures inside 60 days, left as found
  • OPOptions · no verdict drawn today, left as found
  • SCScreen · does not pass the values gate
  • edge confirmed
  • edge broken
  • edge forming

Each arm is one independent read. Conviction is not a single call, it is how many edges converge.

The investor read · the season, not the day

As held on the ledger · 2025-12-31
PhaseMarkdown · caution
Quantitative stateThe statistical read favours the sellers, held for 24 days
Price$0.14
ValuationN/A trailing · -0.11 forward price to earnings
Values screenFAIL · score 70.0
Beta2.04

The business, in plain words · what the numbers mean

The fundamentals · plain-English read
Forward P/E-0.1x
Revenue growth-30.6%
revenue is shrinking
Profit margin-27.2%
currently unprofitable
Current ratio0.55
below 1 — short-term bills exceed liquid assets
Beta2.04
much more volatile than the market
Market cap$1M
Employees44

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings; as a drug manufacturers - specialty & generic name, trial and regulatory outcomes can move it sharply either way.

Plain-English interpretation of our own screen data. Analysis, not advice.

Related securities · others in IMCC's space worth a look

Screened names in the same industry · explore each on its own page.

The trader read · the latest dated commentary

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 38.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 91%. Our forward projection puts the odds of a 10% gain over the next month near 22%. Entered 2026-08-02 · Distribution

The dated journal · newest first, never edited

2026-08-02 Distribution · changed $0.14 -38.1% Entry 4

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 38.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 91%. Our forward projection puts the odds of a 10% gain over the next month near 22%.

2026-07-18 Markup $0.23 +0.0% Entry 3

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 91%. Our forward projection puts the odds of a 10% gain over the next month near 22%.

2026-07-03 Markup $0.23 +0.0% Entry 2

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Markup $0.23 Entry 1

The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $0.25 -9.8% · $902 -9.8%
2 months $0.36 -37.3% · $627 -37.3%
3 months $0.92 -75.4% · $246 -75.4%
6 months $1.67 -86.4% · $136 -86.4%
1 year $2.62 -91.4% · $87 -91.4%
2 years $2.92 -92.3% · $78 -92.3%
3 years $6.54 -96.5% · $35 -96.5%
5 years $369.00 -99.9% · $1 -99.9%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever IMCC does next, these words stay.

IM Cannabis Corp · IMCC · Markdown · $0.14
Recorded 2025-12-31 · before the outcome · scored mechanically

Get our weekly market brief free.